More than half Canada’s AstraZeneca vaccine came from U.S. plant accused of quality-control problems

Close to two thirds of the AstraZeneca COVID-19 vaccine imported into Canada came from a U.S. factory that American authorities say was rife with quality-control issues, Health Canada confirmed Thursday.

The U.S. Food and Drug Administration said this week it will not allow the release of any vaccine made under contract at the Emergent Biosolutions plant in Baltimore, Md. — and still in the U.S.— until it’s been tested further.

Keep reading

Unknown's avatar

Author: HP McLovincraft

Seeker of rabbit holes. Pessimist. Libertine. Contrarian. Your huckleberry. Possibly true tales of sanity-blasting horror also known as abject reality. Prepare yourself. Veteran of a thousand psychic wars. I have seen the fnords. Deplatformed on Tumblr and Twitter.

One thought on “More than half Canada’s AstraZeneca vaccine came from U.S. plant accused of quality-control problems”

  1. Pingback: More than half Canada’s AstraZeneca vaccine came from U.S. plant accused of quality-control problems — Hellbound and Down | Vermont Folk Troth

Leave a comment